[Interim efficacy of a multicenter cohort study for China Net Childhood Lymphoma mature B-cell lymphoma 2017 regimen in the treatment of pediatric High-grade-B cell lymphoma].

• DOI: 10.3760/cma.j.cn112137-20240305-00490
• Publication Date: 2024-07-30
• Authors: Yang Zhao; Shaojun Huang; Yibin Jia; L P Zhang; Yanlong Duan; Ling Jin; X W Zhai; H S Wang; Bo Hu; Ying Liu; A S Liu; Wei Liu; M C Zheng; Fanrong Li; Longhua Sun; Xiaojun Yuan; Y P Dai; B X Zhang; Liang Jiang; X G Wang; Huimin Wang; Chunju Zhou; Ziqing Gao; Y H Zhang
• Keywords: Regimen; Interim; Interim analysis; Follicular lymphoma; B-cell lymphoma

To analyze the mid-term efficacy of China Net Childhood Lymphoma mature B-cell lymphoma 2017 (CNCL-B-NHL-2017) regimen in treating children with high-grade (HGBL).